𝔖 Bobbio Scriptorium
✦   LIBER   ✦

304 A RANDOMIZED, DOUBLE-BLIND, 6-WEEK, DOSE-RANGING STUDY OF PREGABALIN IN SUBJECTS WITH RESTLESS LEGS SYNDROME

✍ Scribed by R. Allen; C. Chen; A. Soaita; C. Wohlberg; L. Knapp; D. Garcia-Borreguero; J. Miceli

Book ID
117776163
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
62 KB
Volume
10
Category
Article
ISSN
1389-9457

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy of pramipexole in restless legs
Efficacy of pramipexole in restless legs syndrome: A six-week, multicenter, randomized, double-blind study (effect-RLS study)
✍ Wolfgang H. Oertel; Karin Stiasny-Kolster; Bettina Bergtholdt; Yngve HallstrΓΆm; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract We evaluated the efficacy of pramipexole versus placebo in restless legs syndrome (RLS) for 6 weeks. Overall, 345 patients were randomly assigned in a 1:2 ratio to receive either placebo (n = 115) or pramipexole (n = 230) with a starting dose of 0.125 mg/day. The dose was individually o

Ropinirole is effective in the treatment
Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study
✍ Arthur S. Walters; William G. Ondo; Tilman Dreykluft; Ron Grunstein; Daniel Lee; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 181 KB πŸ‘ 1 views

## Abstract Restless legs syndrome (RLS) is a neurological condition with significant impact on sleep and quality of life (QoL). This double‐blind, randomized, 12‐week, multinational study compared the efficacy and safety of ropinirole and placebo in RLS. In total, 267 outpatients with moderate‐to‐